Pearl: Participatory Evaluation of Aging with Rapamycin for Longevity
The first large-scale placebo-controlled clinical trial to determine the effects of Rapamycin on human longevity.
- 243% Funded
- $182,838 Funded
-
campaign
complete
AgelessRX
Organization Description
A company providing supplements and treatments believed to increase longevity based on the data from animal and human studies. They also conduct trials and research of their own and include a collection of longevity experts, doctors, and scholars.
Team
Sajad Zalzala, M.D.
AgelessRX - Co-founder
Related Campaigns
